Aadi Bioscience, Inc. (AADI) Tops Q4 EPS by 15c

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q4 EPS of ($0.52), $0.15 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $5.23 million versus the consensus estimate of $4.82 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumble
• More trouble for SpaceX? Analyst flags robotics and space as key bubble risk areas